Clinical Trial Update: Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC) [Phase 1]

View source ↗

Summary

Results from a Phase 1 pre-operative study of IRX-2 in early-stage breast cancer have been completed and posted, including cohorts with triple-negative breast c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Male Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• IRX-2

Snippet

Sponsor: Providence Health & Services | Conditions: Breast Neoplasm, Breast Neoplasm, Male | Phase 1 | Status: COMPLETED | Results posted: 2024-01-30